Roundup Cancer Lawsuit News

Glyphosate Cancer Gets Mixed Reactions Among Scientists

Scientists tell reporters that it is tricky to draw a direct connection between glyphosate usage and cancer

Monday, December 7, 2020 - Reports say that Bayer Monsanto is close to completing the settlement of about two-thirds of the glyphosate cancer cases against them. Plaintiffs allege using Roundup Herbicide caused them to develop cancer. The company denies that its flagship product, Roundup Herbicide, is carcinogenic. There are currently over 125,000 cases against the life sciences conglomerate that claim using Roundup led to developing non-Hodgkin's lymphoma, a rare and deadly form of cancer of the lymph nodes. Bayer Monsanto attorneys defend the product as safe when used as directed and point to opinions stated by the Food and Drug Administration and others that allege to show little increase in the mortality rate from NHL between those that use the product heavily, such as occupational users of Roundup, and those that have never used the product. Individuals with NHL and who have used Roundup Herbicide have hired Roundup Cancer Attorneys to help them file claims against Bayer.

A paper recently published in the San Francisco Public Press titled, "Scientists Split Over Herbicide Risk, Leaving The Public in The Lurch," explained to readers, "Drawing a link between glyphosate exposure and cancer is tricky," said Michael Davoren, a cell biologist at UCLA, specializing in immunology and cancer. Without any type of exposure, one in 50 people will develop non-Hodgkin lymphoma, the type of cancer afflicting the Roundup plaintiffs, he said. People who handle the chemical, such as Dewayne Johnson and Edwin Hardeman, plaintiffs in two lawsuits against Bayer, are only incrementally more likely to succumb to the disease. "Even at the highest levels of exposure like Johnson and Hardeman had, the cancer risk moves up to one in 35," Davoren said. "But cancer won't develop until multiple mutations occur, among other factors."

Three Monsanto cancer trials in recent years have been decided in favor of plaintiffs that used Roundup Weedkiller heavily in their work and would often come into direct skin contact with it. The three plaintiffs all claimed that a chemical in Roundup designed to make it stick to a weed's leaves and stem and not wash off was also responsible for making glyphosate stick to their skin, bioaccumulate, and cause irritations that lead to cancer. The plaintiffs alleged furthermore, that Monsanto had a responsibility to warn occupational and frequent users of the herbicide to wear protective waterproof clothing to prevent them from coming into direct skin contact with the chemical. The first Monsanto glyphosate cancer plaintiff, DeWayne Johnson had emailed Monsanto asking them for guidance when he noticed he was developing skin legions from often "coming home drenched in the weedkiller." Johnson's attorneys showed that the company failed to respond.

Attempts by Bayer to settle the 125,000 claims against them have been met with skepticism. About 40,000 plaintiffs think the settlement offer is too little, too late. Three previous cases that went to court all awarded the plaintiffs about 80 million dollars each after Bayer appealed. Bayer acquired Monsanto in 2018 for $63 billion.

More Recent Roundup Cancer Lawsuit News:

Lawyers for Roundup Cancer Lawsuits

Attorneys handling Roundup cancer lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Roundup cancer lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Roundup cancer lawsuit. The product liability litigators handling Roundup claims at the Onder Law Firm have a strong track record of success in representing families harmed by dangerous drugs and consumer products.